Sec. 28-32. Pharmaceutical preparedness: Definitions. Transfer or distribution of drugs or controlled substances during emergency. (a) For purposes of this
section and section 28-32a:
(1) "Drugs" means (A) substances recognized as drugs in the official United States
Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official
National Formulary, or any supplement to any of said publications; (B) substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in
man or animals; (C) substances, other than food, intended to affect the structure or
any function of the body of man or animals; and (D) substances intended for use as a
component of any article specified in subparagraph (A), (B) or (C) of this subdivision.
"Drugs" does not include devices or their components, parts or accessories;
(2) "Controlled drugs" means those drugs which contain any quantity of a substance
which has been designated as subject to the federal Controlled Substances Act, or which
has been designated as a depressant or stimulant drug pursuant to federal food and
drug laws, or which has been designated by the Commissioner of Consumer Protection
pursuant to section 21a-243 as having a stimulant, depressant or hallucinogenic effect
upon the higher functions of the central nervous system and as having a tendency to
promote abuse or psychological or physiological dependence, or both. Such controlled
drugs are classifiable as amphetamine-type, barbiturate-type, cannabis-type, cocaine-type, hallucinogenic, morphine-type and other stimulant and depressant drugs. "Controlled drugs" does not include alcohol, nicotine or caffeine;
(3) "Controlled substance" means a drug, substance or immediate precursor in
schedules I to V, inclusive, of the Connecticut controlled substance scheduling regulations adopted pursuant to section 21a-243. "Controlled substance" does not include
alcohol, nicotine or caffeine.
(b) Upon declaration of an emergency by the Governor or the Governor's authorized
representative having authority to declare emergencies, a hospital pharmacy, pharmacy
or registrant authorized by state or federal law to be in possession of controlled substances may, in accordance with applicable federal regulations, policies and guidelines
and with prior approval of the Commissioner of Consumer Protection, transfer or distribute drugs or controlled drugs to a licensed pharmacy, a registrant authorized by state or
federal law to be in possession of controlled substances, or a location authorized by the
commissioner. Such registrant shall record the transfer accurately and in compliance
with all state and federal statutes and regulations and shall report the transfer, in writing,
to the commissioner.
(P.A. 06-195, S. 49.)
History: P.A. 06-195 effective June 7, 2006.
| (Return to Chapter Table of Contents) | (Return to List of Chapters) | (Return to List of Titles) |
Sec. 28-32a. Pharmaceutical preparedness: Inventory report. Confidentiality
of information. Regulations. Penalties. (a) Each licensed wholesaler that distributes
prescription drugs, including licensed repackagers of the finished form of controlled
drugs or noncontrolled prescription drug products, shall provide the Commissioner of
Consumer Protection an inventory report regarding such wholesaler's on-hand inventory of specifically identified prescription drugs, in all forms and strengths.
(b) (1) The Commissioner of Consumer Protection shall establish a list of strategic
prescription drugs for which reporting is required pursuant to subsection (a) of this
section. The list shall include, but not be limited to, selected vaccines and antibiotic
products. The list shall be based on priorities established by the commissioner after
consultation with the Commissioner of Public Health. The list shall be based upon anticipated medication requirements for public health preparedness, pharmacological-terrorism prevention or response, and medication and economic integrity and shall be issued
biannually, indicating any additions, substitutions or deletions that have been made to
such list since it was last issued.
(2) An inventory report made pursuant to subsection (a) of this section shall include,
but not be limited to, (A) the name, address, town and state of the wholesaler and manufacturer, (B) the name of the prescription drug, (C) the quantity of the drug on hand,
including the size of each container and number of containers, and (D) the date of the
report. Such information shall be reported at such time and in a manner prescribed by
the Commissioner of Consumer Protection.
(c) Information provided by licensed wholesalers pursuant to this section shall not
be subject to disclosure under the Freedom of Information Act, as defined in section 1-200, and shall be available only to the Department of Consumer Protection, the Department of Public Health, the Office of Emergency Management and such other agencies
or entities as the Commissioner of Consumer Protection determines, after request by
such agency or entity and demonstration of a need for the information for purposes of
public health preparedness, pharmacological-terrorism prevention or response, medication integrity or such other purpose deemed appropriate by the commissioner.
(d) The Commissioner of Consumer Protection, with the advice and assistance of
the Commission of Pharmacy, may adopt regulations, in accordance with chapter 54,
to carry out the provisions of this section.
(e) Any person who violates the provisions of subsection (a) of this section shall
be fined not more than ten thousand dollars or imprisoned not more than one year, or both.
(P.A. 06-195, S. 50.)
History: P.A. 06-195 effective June 7, 2006.
| (Return to Chapter Table of Contents) | (Return to List of Chapters) | (Return to List of Titles) |
| (Return to Chapter Table of Contents) | (Return to List of Chapters) | (Return to List of Titles) |